Barclays
NPSP

Barclays’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Barclays’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-97,400
Closed -$3.41M – 7497
2014
Q4 		$3.41M Sell
97,400
-367,700
-79% -$11M ﹤0.01% 2035
2014
Q3 		$12.1M Buy
465,100
+237,000
+104% +$6.81M 0.01% 1045
2014
Q2 		$7.53M Buy
228,100
+181,800
+393% +$5.25M 0.01% 1378
2014
Q1 		$1.34M Sell
46,300
-24,200
-34% -$834K ﹤0.01% 2929
2013
Q4 		$2.12M Buy
70,500
+26,100
+59% +$719K ﹤0.01% 2616
2013
Q3 		$1.38M Sell
44,400
-52,800
-54% -$1.21M ﹤0.01% 2998
2013
Q2 		$1.47M Buy
+97,200
New +$1.35M ﹤0.01% 2886

Other funds holding NPSP

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Barclays's NPSP Position: Q1 2015 in Review

Barclays sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 205,448 shares — an estimated $7.19M sold.

Barclays first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $7.19M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • Barclays reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Barclays sold 205,448 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $7.19M.
  • Barclays first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Barclays's NPS PHARMACEUTICALS INC position peaked at $7.19M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.